Scopri le migliori cliniche e prezzi per il trattamento di Glioblastoma in Italia 2026

Top hospitals in Italy for glioblastoma treatment include San Raffaele Hospital, Humanitas Research Hospital, and Agostino Gemelli University Policlinic. These centers offer advanced neuro-oncology, 3 Tesla MRI imaging, and specialized neurosurgery. Many institutions maintain JCI accreditation and IRCCS status for excellence in clinical research.

• Advanced radiosurgery: San Raffaele Hospital has performed over 10,000 Gamma Knife procedures.
• Specialized neurosurgery: Dr. Pietro Mortini at San Raffaele specializes in complex microsurgical brain therapies.
• High patient volume: San Donato Hospital treats approximately 300,000 patients annually across various departments.
• Integrated research: IRCCS-accredited centers combine patient assistance with active clinical and molecular research.

Bookimed Expert Insight: While many patients look for large cancer centers, the IRCCS accreditation is the most reliable quality signal in Italy. This government-granted status confirms a hospital integrates the latest research directly into clinical practice. San Donato Hospital holds this distinction, ensuring patients access diagnostic protocols that meet high national research standards.

Patient Consensus: Patients note that Milan-based centers offer the best trial access but suggest using private options to reduce wait times. Many emphasize the importance of identifying MGMT methylation status early for personalized chemotherapy planning.

Standard care in Italy follows the Stupp protocol, combining maximal surgical resection with direct adjuvant therapy. Specialists utilize advanced imaging like 5-ALA fluorescence to define tumor margins. This is followed by 6 weeks of radiation and temozolomide chemotherapy. Treatment usually begins within 2–4 weeks of diagnosis.

• Surgical resection: Surgeons aim for maximal tumor removal while preserving critical neurological functions.
• Stupp regimen: Protocol includes 60 Gy radiation with daily oral temozolomide chemotherapy.
• Maintenance phase: Patients undergo 6 to 12 cycles of chemotherapy after a 4-week recovery.
• Genetic profiling: MGMT promoter methylation testing is standard to predict chemotherapy response.
• Recurrence options: Treatment may include regorafenib, second-line surgery, or Tumor Treating Fields (TTFields).

Bookimed Expert Insight: Italian neuro-oncology emphasizes high-volume surgical expertise. Academic centers like San Raffaele in Milan manage complex cases with surgeons like Dr. Pietro Mortini who has 30+ years of experience. Research-focused IRCCS facilities integrate clinical trials and advanced diagnostics directly into the standard treatment pathway. This structure often allows for a faster transition from surgery to radiation compared to other European systems.

Patient Consensus: Patients note that major centers in Milan and Rome offer very fast access to surgery. They emphasize the importance of having a multidisciplinary tumor board review every imaging scan to track recovery progress.

Specialized glioblastoma care in Italy includes Gamma Knife radiosurgery and advanced resection techniques. Leading research institutions provide access to CAR NK cell therapy and oncothermia. Patients may also qualify for regional clinical trials exploring immunotherapy and localized chemotherapy delivery protocols.

• Surgical innovation: Neurosurgeons use Halcyon and microsurgical techniques for precise tumor resection.
• Radiosurgery access: Gamma Knife provides targeted radiation while sparing surrounding healthy brain tissue.
• Cellular immunotherapy: CAR NK cell therapy is available as a specialized treatment approach.
• Clinical research: IRCCS-accredited centers combine patient care with experimental ministry-approved research activity.

Bookimed Expert Insight: Italian neurosurgery stands out because top specialists often hold international academic roles. For example, Dr. Pietro Mortini at San Raffaele has patented biological tissue regeneration devices. Choosing a surgeon with 30+ years of experience who also leads research ensures access to the latest surgical patents and experimental tools before they go mainstream.

Patient Consensus: Patients note that finding clinical trials in Italy requires self-advocacy and checking global registries earlier than expected. They often recommend specifically asking about Optune therapy, as it is a standard non-experimental option that medical teams sometimes overlook.

Italian centers treating glioblastoma provide dedicated support for international patients through specialized infrastructure. Professional medical interpreters and multilingual staff facilitate English-speaking consultations. Hospitals in Milan and Bari often offer logistical help with medical records, travel visas, and lodging arrangements.

• Language support: Free interpretation is common in facilities receiving specific government funding.
• Coordination services: Dedicated representatives assist with appointment scheduling and travel logistics.
• Medical translation: Certified translators ensure technical terms in consent forms are clear.
• Cultural assistance: Staff are often trained to meet diverse religious and linguistic needs.

Bookimed Expert Insight: Patient volume impacts support quality in Italy. San Donato Hospital manages 300,000 patients annually with a staff of 350 doctors. This high traffic usually means they have established systems for international visitors. Choosing a specialist like Dr. Pietro Mortini at San Raffaele provides access to world-class neurosurgery and experienced multilingual coordination teams.

Patient Consensus: Patients note it is important to hire a certified medical translator for technical discussions. They also recommend targeting private hospital wings where English access is more consistent.

Italy provides comprehensive standard care for glioblastoma, including surgical resection, radiation, and chemotherapy. Specialised neuro-oncology centres in Milan and Pavia follow the international Stupp protocol. They use technologies like Gamma Knife, neuronavigation, and genetic MGMT testing.

• Surgical expertise: Specialists like Dr Pietro Mortini in Milan perform minimally invasive brain operations.
• Radiosurgery: Centres use Gamma Knife and CyberKnife systems for precise tumour targeting.
• Imaging protocols: Facilities include San Donato Hospital, which holds IRCCS research and assistance accreditation.
• Clinical standards: Italian neuro-oncology units use neuronavigation and neuromapping to protect healthy tissue.

Bookimed Expert Insight: Top results come from IRCCS-accredited centres like San Donato Hospital. These facilities combine research with clinical care. They often provide faster access to specialised neuro-oncology teams. Choosing a dedicated unit ensures surgery, radiotherapy, and pathology reviews are coordinated seamlessly.

Patient Consensus: Patients highlight that finding a dedicated neuro-oncology unit in Italy is vital for coordination. They suggest checking that imaging and surgery are arranged quickly. This helps to start follow-up radiation on schedule.

Italian glioblastoma care uses multidisciplinary teams (MDT) within specialised Scientific Institutes for Research and Healthcare (IRCCS). These groups include neurosurgeons, neuro-oncologists, and radiation oncologists. They work together to plan surgery and systemic therapies. Leading centres include San Raffaele and San Donato Hospital in Milan.

• Surgical lead: Neurosurgeons perform tumour resection using neuronavigation and neuromapping technologies.
• Systemic coordination: Neuro-oncologists manage chemotherapy, targeted therapies, and emerging CAR NK cell treatments.
• Radiation planning: Specialists use platforms like Halcyon or Gamma Knife for precise radiotherapy.
• Diagnostic depth: Neuroradiologists and neuropathologists interpret contrast MRIs and perform molecular profiling.

Bookimed Expert Insight: Italian neuro-oncology thrives on the IRCCS model. This model integrates clinical care with experimental research. Dr Pietro Mortini at San Raffaele directs a dedicated experimental unit. This provides patients with innovative surgical techniques and patented tissue regeneration technologies. These are often not found in standard hospitals. It bridges the gap between traditional surgery and new treatments.

Patient Consensus: Patients find the Italian system works best when accessing verified IRCCS centres. This occurs through official neuro-oncology pathways. Specialists from Australia can often help coordinate these care handovers for complex brain tumours.

International patients can access experimental glioblastoma treatments in Italy through IRCCS-accredited research hospitals. These centres combine specialised care with regulated clinical trials. Access often involves techniques like biological tissue regeneration. Eligibility depends on molecular markers and treatment history rather than nationality.

• Research accreditation: IRCCS centres like San Donato Hospital combine clinical assistance with research approved by the ministry.
• Expert leaders: Prof. Pietro Mortini at San Raffaele directs experimental neurosurgery. He also holds tissue regeneration patents.
• Specialised technology: Facilities provide Gamma Knife radiosurgery, neuronavigation, and neuromapping for precise tumour targeting.
• Trial networks: Italian institutions join global platforms like GBM AGILE for access to innovative therapy.

Bookimed Expert Insight: IRCCS-accredited centres like San Donato Hospital are the primary hubs for research. These institutions serve 300,000+ patients annually. They integrate laboratory findings directly into clinical practice. Patients should target these research centres to find protocols like CAR NK cell therapy or oncothermia.

Patient Consensus: Patients note that eligibility criteria like tumour markers are the main barrier. Success in Italy often requires translated medical records. Patients must also confirm if specific trials accept non-residents.

Italy offers high-standard glioblastoma care at specialised research institutes known as IRCCS. Leading centres in Milan and Rome provide multidisciplinary neuro-oncology teams. These facilities use technologies like neuronavigation and Gamma Knife. Specialists often participate in global clinical trials for aggressive brain tumours.

• Milan hubs: San Donato hospital holds IRCCS accreditation from the Italian Health Ministry.
• Expert specialists: Prof. Pietro Mortini at San Raffaele specialises in minimally invasive brain surgery.
• Techniques: Centres use neuromapping and neuronavigation to preserve healthy brain tissue.
• Research focus: IRCCS facilities combine clinical care with neurological research for complex cases.

Bookimed Expert Insight: Italy has numerous local hospitals. However, data shows Milan is the primary hub for complex neuro-oncology. San Donato hospital serves 300,000 patients annually and carries Newsweek's World's Best Hospitals 2021 ranking. This volume suggests high-level expertise in managing glioblastoma care.

Patient Consensus: Patients recommend choosing large university-affiliated centres in Milan rather than smaller clinics. They note that checking for dedicated neuro-oncology pathways is vital. International arrivals should also look for English-speaking coordinators.

Australian patients can travel to Italy for glioblastoma treatment through private arrangements at research hospitals. Logistics require medical clearance for long-haul flights. Italian neurosurgeons must also review MRI scans before travel. Specialised centres in Milan and Bari provide therapies like Gamma Knife, chemotherapy, and neuro-mapping.

• Clinical leadership: Dr Pietro Mortini at San Raffaele specialises in neuro-oncology and minimally invasive brain operations.
• Technology: Italian facilities use Gamma Knife radiosurgery and Halcyon platforms for precise radiation delivery.
• Specialist accreditation: San Donato Hospital in Milan holds IRCCS status, combining clinical care with research.
• Travel safety: Patients require GP approval for high-altitude travel due to potential seizure risks.

Bookimed Expert Insight: While many seek clinical trials, Italy's logistical advantage lies in research-heavy IRCCS centres. San Donato hospitals treat 300,000+ patients annually and integrate new protocols quickly. For Australians, this means access to niche treatments like Actinium-225 therapy that remain limited elsewhere.

Patient Consensus: Patients emphasise that glioblastoma moves fast. Having an Italian centre review MRIs before booking flights is vital. Carrying local pathology reports and a dedicated travel companion helps with communication and monitoring symptoms in Italy.